Skip to main content
. 2019 Dec 29;12(1):82. doi: 10.3390/cancers12010082

Table 1.

Sequences of primers used in the study.

Gene Accession Number Forward Primer Reverse Primer
GAPDH NM_008084 AACGGCACAGTCAAGGCCGA ACCCTTTTGGCTCCACCCTT
Nanog NM_028016.3 AGGGTCTGCTACTGAGATGCTCTG CAACCACTGGTTTTTCTGCCACCG
OCT3/4 NM_013633.3 TCTTTCCACCAGGCCCCCGGCTC TGCGGGCGGACATGGGGAGATCC
SOX2 NM_011443.4 TAGAGCTAGACTCCGGGCGATGA TTGCCTTAAACAAGACCACGAAA
CD133 NM_001163578.1 CCTTGTGGTTCTTACGTTTGTTG CGTTGACGACATTCTCAAGCTG
CD44 NM_009851.2 AGAAAAATGGCCGCTACAGTATC TGCATGTTTCAAAACCCTTGC
CD90 NM_009382.3 TGCAGCTAGGGGAGTCCAGAAT TCCAGGCGAAGGTTTTGGTT
c.kit NM_021099.3 CGGACAGCACCAAGCACATTTACTC AACCATCACAGAAGCCAGAAGGACG
CD34 NM_001111059.1 TGCTGCATCTAAATAACTTGAC AGGGATCCCAGAGGTAACTG
RUNX1 NM_001111021.2 CTGCCCATCGCTTTCAAGGTG CTATGGTAGGTGGCAACTTGTGG
CD38 NM_007646.5 TGAGAGATCAGAACTGCCAGG GTGTCCTCCAGGGTGAACAT
CD10 NM_008604.4 GCTAGAAGTCATTTTGAAAGATGTCCT AGTGCCATATGTTTGATCCCAGT
CD11b NM_001082960.1 TACGTAATTGGGGTGGGAA GTGCCCTCAATTGCAAAGAT
CD14 NM_009841.3 CTCTGTCCTTAAAGCGGCTTAC GTTGCGGAGGTTCAAGATGTT
F4/80 NM_010130.4 CACCGGTATAGACAAGACTGACA TCTCACCATCAGGAAGAGCA
CD68 NM_009853.1 ACTTCGGGCCATGTTTCTCT GCTGGTAGGTTGATTGTCGT
GFP GACAAGCAGAAGAACGGCATCAAGG CTCAGGTAGTGGTTGTCGGGCAG